Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,986.83
2,646.21
1,901.24
2,464.78
2,642.89
1,927.35
1,413.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,986.83
2,646.21
1,901.24
2,464.78
2,642.89
1,927.35
1,413.83
Raw Material Cost
494.08
581.11
440.25
480.60
432.83
305.16
210.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
339.20
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
53.94
64.22
55.29
36.51
14.55
1.29
0.23
Selling and Distribution Expenses
599.77
857.84
762.65
815.83
715.30
575.24
527.41
Other Expenses
10.89
13.44
15.63
19.79
14.91
7.64
-27.28
Total Expenditure (Excl Depreciation)
1,256.72
1,637.62
1,414.49
1,530.84
1,311.75
958.06
804.81
Operating Profit (PBDIT) excl Other Income
730.1
1008.6
486.70000000000005
933.9
1331.1000000000001
969.3000000000001
609
Other Income
42.71
79.55
121.56
135.92
99.50
69.74
68.25
Operating Profit (PBDIT)
888.25
1,219.51
716.36
1,143.82
1,481.84
1,072.61
703.68
Interest
53.94
64.22
55.29
36.51
14.55
1.29
0.23
Exceptional Items
-37.93
-4.17
-27.07
-7.88
-1.33
-0.48
-1.35
Gross Profit (PBDT)
1,492.75
2,065.10
1,460.99
1,984.18
2,210.07
1,622.19
1,203.04
Depreciation
136.25
144.15
112.98
82.62
58.74
38.89
30.81
Profit Before Tax
660.13
1,006.96
521.02
1,016.81
1,407.22
1,031.95
671.28
Tax
128.46
192.78
95.30
135.89
211.38
158.95
102.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
532.82
820.20
436.49
889.54
1,196.81
875.24
570.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
532.82
820.20
436.49
889.54
1,196.81
875.24
570.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.15
-6.01
-10.77
-8.62
-0.97
-2.24
-2.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
531.67
814.19
425.72
880.92
1,195.84
873.00
568.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,471.72
3,333.91
3,147.48
3,574.28
3,358.86
2,806.79
2,142.47
Earnings per share (EPS)
0.69
1.08
0.55
1.11
1.49
1.08
0.72
Diluted Earnings per share
0.69
1.08
0.55
1.11
1.49
1.08
0.72
Operating Profit Margin (Excl OI)
35.7%
37.63%
25.34%
37.54%
50.08%
50.02%
42.76%
Gross Profit Margin
40.08%
43.5%
33.35%
44.61%
55.47%
55.56%
49.66%
PAT Margin
26.82%
31.0%
22.96%
36.09%
45.28%
45.41%
40.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -24.92% vs 39.19% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -34.70% vs 91.26% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -25.83% vs 91.66% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -16.04% vs 16.09% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Jafron Biomedical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,986.83
0
1,986.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,986.83
0
1,986.83
Raw Material Cost
494.08
0
494.08
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
53.94
0
53.94
Selling and Distribution Expenses
599.77
0
599.77
Other Expenses
10.89
0.00
10.89
Total Expenditure (Excl Depreciation)
1,256.72
0
1,256.72
Operating Profit (PBDIT) excl Other Income
730.11
0.00
730.11
Other Income
42.71
0
42.71
Operating Profit (PBDIT)
888.25
0
888.25
Interest
53.94
0
53.94
Exceptional Items
-37.93
0
-37.93
Gross Profit (PBDT)
1,492.75
0
1,492.75
Depreciation
136.25
0
136.25
Profit Before Tax
660.13
0
660.13
Tax
128.46
0
128.46
Provisions and contingencies
0
0
0.00
Profit After Tax
532.82
0
532.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
532.82
0
532.82
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.15
0
-1.15
Other related items
0.00
0.00
0.00
Consolidated Net Profit
531.67
0
531.67
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,471.72
0
3,471.72
Earnings per share (EPS)
0.69
0
0.69
Diluted Earnings per share
0.69
0
0.69
Operating Profit Margin (Excl OI)
35.70%
0%
0.00
35.70%
Gross Profit Margin
40.08%
0%
0.00
40.08%
PAT Margin
26.82%
0%
0.00
26.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 198.68 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -24.92% vs 39.19% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 53.17 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -34.70% vs 91.26% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 84.55 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -25.83% vs 91.66% in Dec 2024
Annual - Interest
Interest 5.39 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.04% vs 16.09% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.70%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






